BDF
AGN

Balasa Dinverno & Foltz’s Allergan plc AGN Stock Holding History

Balasa Dinverno & Foltz’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,411
Closed -$420K – 215
2015
Q1 		$420K Buy
+1,411
New +$402K 0.06% 101

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Balasa Dinverno & Foltz's AGN Position: Q2 2015 in Review

Balasa Dinverno & Foltz sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 1,411 shares — an estimated $420K sold.

Balasa Dinverno & Foltz first reported a position in AGN in Q1 2015 and held it in 1 quarter. The position peaked at $420K in Q1 2015. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Balasa Dinverno & Foltz reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Balasa Dinverno & Foltz sold 1,411 Allergan plc shares in Q2 2015, an estimated $420K.
  • Balasa Dinverno & Foltz first reported a position in Allergan plc in Q1 2015 and held it in 1 quarter.
  • Balasa Dinverno & Foltz's Allergan plc position peaked at $420K in Q1 2015.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Balasa Dinverno & Foltz's 13F filing for Q2 2015, filed 11 Aug 2015.